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intake, and S Alb . The results also suggest that the lower tHcy Background. Hyperhomocysteinemia, cardiovascular disease levels in patients with CVD than in those without CVD may (CVD), and malnutrition are common in patients with endbe related to the higher prevalence of malnutrition and hypoalstage renal disease (ESRD). This study was designed to assess buminemia in the CVD patients. This is also in accordance possible relationships between total plasma homocysteine with our observation that the patients with lower tHcy had a (tHcy), nutritional status, and ischemic CVD.
worse survival rate than those with higher tHcy, considering Methods. We performed a cross-sectional study in 117 unsethat malnutrition is a strong risk factor for mortality and that lected patients on maintenance hemodialysis (HD) treatment, CVD is the most common cause of death in ESRD patients. among whom there was a high prevalence of malnutrition (56%), as assessed by the subjective global nutritional assessment (SGNA), and a high prevalence of CVD (60%), and prospectively, we followed-up the overall mortality for four years.
Hyperhomocysteinemia is considered an independent
Results. The level of tHcy was elevated in 95% of the HD risk factor for atherosclerosis in the general population patients, and that of total plasma cysteine (tCys) was also [1, 2] . However, the relationship between hyperhomosignificantly elevated, while the plasma concentrations of methionine (Met), serine (Ser), and taurine (Tau) were significysteinemia and vascular events is complex and not well cantly lower than those in healthy controls. The 65 patients understood, and it is not clear why a high level of plasma who were malnourished according to the SGNA score had total homocysteine (tHcy) appears to promote atherosignificantly lower levels of serum albumin (S Alb ), plasma IFG-1 sclerosis. Experimental studies suggest that homocysteine (p-IGF-1), tHcy, tCys, and Met than the 52 patients with normal may enhance lipoprotein oxidation, increases smooth nutritional status, whereas the levels of Ser, Tau, plasma folate, and vitamin B 12 were similar in the two groups. The prevalence muscle cell proliferation, induces endothelial dysfuncof malnutrition was 30% in the 47 patients without CVD and tion, induces endothelial activation of factor V, and rewas significantly higher (70%, P Ͻ 0.001) in the 70 patients duces protein C activation by arterial and venous endowith CVD, who also had lower tHcy, S Alb , plasma IGF-1, serum thelial cells [3] . creatinine (S Cr ), and blood hemoglobin. The tHcy levels were
The risk of premature and progressive occlusive vascupositively correlated with S Alb , Met, tCys, and S Cr . Stepwise, multiple-regression analysis showed that tCys, S Alb , and normallar disease is high in chronic uremic patients and accounts ized protein equivalent of nitrogen appearance (nPNA), an for more than 40% of the deaths in dialysis patients indicator of protein intake, were independent predictors of [4] . The mechanism is unclear, although hypertension, tHcy. The patients with tHcy Ͻ24 mol/L (median value) had disorders of lipid metabolism, glucose intolerance, smoka significantly worse four-year survival than those with a higher ing, and anemia, as well as inflammation/infection, may tHcy (Ն24 mol/L).
Conclusions. Our results demonstrate that most of HD pabe relevant [4, 5] . In addition, malnutrition in uremic patients may be a predisposing factor to cardiac disease or may contribute to a poor prognosis by aggravating
The aim of this cross-sectional study was to analyze of water-soluble vitamins, including l-pyridoxine chloride (10 mg daily) but not folic acid or vitamin B 12 . plasma sulfur amino acids (sAA) in hemodialysis (HD) patients with normal nutritional status, malnourished Thirty-five healthy subjects (23 male and 12 female), aged 38 (21 to 64) years, were subjected to comparative HD patients, and healthy subjects and to assess, in the HD patients, the relationship between tHcy levels, nutrianalysis of nutritional parameters and amino acids, including tHcy. tional status, and CVD. The HD patients were then followed over a four-year period to assess the overall mortalThe Ethics Committee of the Karolinska Institute at Huddinge University Hospital (Stockholm, Sweden) apity in relationship to basal tHcy levels. A preliminary report of our findings that chronic renal failure patients proved the protocol of the study, and informed consent was obtained from each HD patient and healthy subject. with cardiovascular disease (CVD) had a lower tHcy level than patients without CVD was presented at the Subjective global nutritional assessment Annual Meeting of the American Society of Nephrology (abstract; Suliman et al, J Am Soc Nephrol 7:1325 Nephrol 7: , 1996 .
Subjective global nutritional assessment (SGNA) was used to evaluate the overall protein-energy nutritional status [9] [10] [11] . SGNA includes six subjective assessments, METHODS three based on the patient's history of weight loss, inciSubjects dence of anorexia, and incidence of vomiting, and three based on the physician's grading of muscle wasting, presIt was our intention that all HD patients at dialysis ence of edema, and loss of subcutaneous fat. These varicenters affiliated with Huddinge University Hospital ables were graded as: 1 ϭ none, 2 ϭ mild, 3 ϭ moderate, should participate in a cross-sectional study of nutritional and 4 ϭ severe. The sum of the respective scores of status, as previously reported [7] . Of the 128 patients the six subjective assessments was considered to be an who agreed to participate, plasma samples for determiordinal variable in the statistical analysis. We divided nations of Hcy and other related amino acids were obthe patients into two groups according to the SGNA tained in 117 patients (71 male and 46 female) aged 65 score. Patients with an ordinal SGNA score between six (26 to 85) years. The causes of renal failure in the 117 and eight were placed in group I (normal nutritional patients included diabetic nephropathy (N ϭ 23), chronic status), and those with an ordinal SGNA score equal to glomerulonephritis (N ϭ 34), polycystic kidney disease or more than nine were placed in group II (mild to severe (N ϭ 11), pyelonephritis and interstitial nephritis (N ϭ malnutrition). 12), and other unspecified diseases or unknown causes (N ϭ 37). Thirteen of the diabetic patients were insulin Anthropometric measurements dependent. Fifty-seven patients had ischemic CVD (ICVD) at the time of entering the study; that is, they Anthropometric and dynamometer measurements were carried out in the morning after the collection of blood had had one or more myocardial infarctions (N ϭ 18), angina pectoris (N ϭ 14), aortic aneurysm (N ϭ 1), samples. Triceps skinfold thickness (TSF) was measured in all subjects using the Harpenden caliper on the nonperipheral vascular diseases (N ϭ 18), or a history of cerebrovascular accident (N ϭ 6) with neurological dominant arm in the healthy subjects and the fistula-free arm in the HD patients. The midarm muscle circumfersymptoms following one or more attacks of strokes. All patients underwent electrocardiography (ECG). ence (MAMC) was derived from the TSF and midarm circumference (MAC) as follows: MAMC ϭ MAC Ϫ Thirteen patients had chronic heart failure but did not show clinical manifestations of ICVD or ischemic ECG ( * TSF). Hand-grip strength (HGS) was measured using the Harpenden dynamometer. Subjects were inchanges. Eighty-six patients had no residual renal function, defined as a renal urea clearance Ͻ0.5 mL/min. The structed to apply as much hand-grip pressure as possible, using both hands. Dynamometry was repeated three protein intake was estimated by calculating the protein equivalent of nitrogen appearance normalized to body times, and the highest score was recorded. The desirable body weight was calculated in accordance with the paweight (nPNA), based on urea kinetic modeling [8] .
The patients were treated with oral sodium bicarbontient's height, sex, and frame-size match, using Metropolitan height and weight tables [12] . The individual values ate and calcium carbonate as required to prevent acidosis and hyperphosphatemia. Forty patients were treated for anthropometric variables (TSF, MAMC, and HGS) were normalized by converting them to a percentage of with antihypertensive drugs such as angiotensin-converting enzyme inhibitors, ␤ blockers, and calcium blockthe mean values of healthy subjects for the same sex. The SGNA and the anthropometric measurements were ers. Fifteen patients with residual renal function were treated with high doses of furosemide (250 to 500 mg/ made by one investigator (A.R.Q.) who had experience with these methods. He was not aware of the biochemical day). Recombinant human erythropoietin was given to 66 patients. All patients were given routine supplements data at the time of examination. 
RESULTS
a The assessment % desirable body weight was based on medium frame-size individuals [12] Fifty-two HD patients (44%) had a normal nutritional b Expressed as % of values in the HS of the same sex c Significant differences between groups I and II, P Ͻ 0.05 status (group I), and 65 patients (56%) were mildly to severely malnourished (group II), based on SGNA (Table 1). The distribution of primary causes of renal failure was essentially similar in the two groups of HD patients, Biochemical analyses except for a higher frequency of diabetes mellitus in Venous blood samples from HD patients and control group II (N ϭ 18) than in group I (N ϭ 5). CVD was subjects were collected in the morning after an overnight present in 60% of all the patients and in 78% of the fast. The HD patients were investigated on a midweek, malnourished patients. The duration of HD treatment dialysis-free day. As previously described, plasma-free was significantly (P ϭ 0.03) longer in group I, 25 months amino acid concentrations [13] and tHcy and plasma (range, 0.5 to 317 months) versus 14 months (range, 0.5 total cysteine (tCys) concentrations [14] were deterto 88 months) in group II. As expected, the malnourished mined with high-performance liquid chromatography. patients were older and had a lower percentage of desirSerum albumin (S Alb ), serum creatinine (S Cr ), blood urea, able body weight, MAC, TSF, HGS, S Alb , and plasma serum C-reactive protein (S CRP ), and plasma insulin-like IGF-1 (Table 1 ) than the well-nourished patients. The growth factor-1 (IGF-1) were determined as prescribed mean values of nPNA, plasma folate, and plasma vitamin earlier [7] . Plasma folate concentration was determined B 12 concentrations were similar in the two patient groups. with the Dualcount SPNB (solid phase no boil) radioim- Table 2 shows that the tHcy and tCys were significantly munoassay kit from Diagnostic Product Corporation higher in the patient groups than in healthy subjects, (Los Angeles, CA, USA).
whereas plasma methionine (Met), plasma taurine (Tau), and plasma serine (Ser) concentrations were lower in Statistical analyses the HD patients. The Met, tHcy, and tCys concentrations Differences between the three groups were analyzed were significantly lower in group II (malnourished) paby analysis of variance (ANOVA). When the ANOVA tients than in group I. There were no significant differwas found to be significant at P Ͻ 0.05, Dunnett's test ences in Tau and Ser concentrations between the two was used to compare the differences between the healthy patient groups. subjects and HD patient groups. Comparisons between Hyperhomocysteinemia was present in the vast majortwo groups were assessed for continuous variables by ity of the 117 HD patients, 95% of all patients, 90% of the Student's t-test, the Mann-Whitney test was used the HD patients with CVD, and 96% of the patients when distribution was skewed, and for nominal variables without CVD had tHcy levels Ͼ13 mol/L (Ͼ95th perby the chi-square test. Spearman's rank correlation was centile of the tHcy level in healthy subjects). Dividing used to determine correlations between variables.
Stepwise multiple-regression analysis was applied to identify the HD patients into two groups, based on presence of Table 3 , we found that HD patients A correlation matrix, presenting Spearman's rank corwith CVD were older and had lower S Alb levels than relation coefficients for the HD patients, is shown in those without CVD. The tHcy concentration was lower Table 4 . The SGNA score was negatively correlated with in HD patients with CVD than in those without CVD S Alb , S Cr , tCys, tHcy, IGF-1, and Met levels, but it was (Table 3) , and this difference was also present after exnot significantly correlated with nPNA and S CRP . Plasma cluding the 13 HD patients with chronic heart failure tHcy was positively correlated with S Alb , tCys, and S Cr who had no signs of ischemia (Table 3 and Fig. 1 ). The levels, as shown in Figure 2 , and was also correlated with plasma folate and vitamin B 12 concentrations were simiMet, but did not correlate with S CRP (Table 4) , plasma lar in the two patient groups, and the concentrations of folate (r ϭ Ϫ0.15, P ϭ 0.11), and plasma B 12 (r ϭ Ϫ0.05, folate and B 12 , in all HD patients, were within the normal P ϭ 0.6). Serum albumin was also positively correlated range [15] . The levels of plasma IGF-1, blood hemoglowith Met, tCys, and IGF-1, and negatively correlated bin, and S Cr were significantly lower in patients with with S CRP . In addition, tCys was positively correlated with CVD. The proportion of patients with serum S CRP Ͼ10
Met and S Cr . Normalized PNA was positively correlated mg/L was also similar in the two groups of patients.
with Met and inversely with S CRP . There were more males among the HD patients with
Stepwise multiple-regression analysis was used to find CVD than in those without CVD (72 vs. 52%, P ϭ significant independent predictors of tHcy in the HD 0.03). Therefore, we also evaluated males and females patients (Table 5 ). Plasma Cys (r 2 ϭ 0.23) was the strongseparately to determine the tHcy concentration. In male HD patients, the tHcy level was significantly lower in est predictor, followed by S Alb (r 2 ϭ 0.11) and protein intake (r 2 ϭ 0.04), as assessed by nPNA. The regression patients with CVD than in those without (24 Ϯ 13 vs. 32 Ϯ 16 mol/L, respectively, P ϭ 0.02), whereas the model could explain 38% of the variation in tHcy. Omitting tCys from the model reduced the adjusted total r 2 levels were not significantly different in female HD patients with or without CVD (25 Ϯ 12 vs. 28 Ϯ 11 mol/L, from 0.38 to 0.17. The median level of tHcy in the HD patients was 24 respectively, P ϭ 0.5). Among the 52 male patients aged 50 years or more at the time of the study, the tHcy mol/L. The cumulative Kaplan-Meier survival analysis of patients with tHcy Ն24 mol/L and Ͻ24 mol/L concentration in those with CVD (N ϭ 32) was 24.9 Ϯ 14.2 mol/L, and in those without CVD (N ϭ 20) , it was showed a significantly worse survival in those with lower tHcy levels (Fig. 3) . Figure 3 represents the overall mor-31.6 Ϯ 18.2 mol/L (P ϭ 0.07).
The median age of the HD patients was 65 years. tality of HD patients and not only mortality caused by cardiovascular events. Those more than 65 years of age had lower S Alb levels 
DISCUSSION
mans [19] . Disturbed methylation reactions caused by uremia or cofactor (folate, vitamin B 6 ) deficiency have The results of the present study demonstrate a high also been thought to contribute to hyperhomocysteineprevalence of hyperhomocysteinemia in HD patients, mia [20] . Moreover, the extrarenal Hcy metabolism may thus confirming earlier reports. However, the precise decrease because of the inhibition by retained metabomechanism of hyperhomocysteinemia in chronic renal lites [21] . Supplementation with vitamins (folate, vitamin failure remains unclear. Reduced renal excretion [16] B 6 ) reduces but generally fails to normalize elevated Hcy and decreased renal uptake [17, 18] of Hcy have been levels in uremia [22] . reported, but recent findings do not show that renal elimination of Hcy is of any significance in normal huWe observed ( Table 2 ) that the levels of tHcy and tCys were elevated and significantly correlated (Fig. 2) , and that in multifactorial analysis tCys was the strongest predictor of tHcy. Moreover, the levels of Met (the pre- cursor essential sAA) and Tau (an end-product of Met
The patients were divided into two groups according to the plasma metabolism) were low. These findings are consistent with total homocysteine level, that is, Ͻ24 mol/L (solid line) and Ն24 mol/L (dashed line). This figure represents the overall mortality of our previous observation in smaller groups of HD pa-HD patients and not only mortality caused by cardiovascular events.
tients [13, 22, 23] . We also reported earlier that plasma
Difference between the groups: P ϭ 0.02.
and muscle Tau are depleted in dialysis patients [24] [25] [26] and that the plasma levels of cysteinesulfinic acid (CSA) are elevated [13] . We speculated earlier that inhibition trition, based on the concept that the level of S Alb reflects of Tau synthesis from CSA might have a role in the the visceral protein status. However, protein intake and development of hyperhomocysteinemia in renal failure various catabolic factors, as well as nonnutritional factors patients [13] . However, a recent study using stable isomay influence S Alb [31] . Accordingly, S Alb levels may not topes demonstrates that homocysteine remethylation only reflect protein malnutrition [32, 33] . In this study, rather than transsulfuration is decreased in renal failure S Alb was related to inflammation, as assessed by the S CRP patients [27] .
(inversely correlated), but no relationship was found between S CRP and tHcy (Table 4) , therefore suggesting that Homocysteine, nutritional status, and serum albumin the relationship between tHcy and S Alb most likely was To investigate the relationship between tHcy levels not due to inflammation. and nutritional status in HD patients, we divided the In this study, the protein intake, estimated from the patients according to the SGNA into two groups. The nPNA, did not differ between the two groups of patients. patients in group II (malnourished group; Table 1) had However, in a stepwise multiple-regression model, we low S Alb and anthropometric measurements (percentage found that nPNA, an indicator of protein intake, was of desirable body weight, fat mass, MAMC, TSF, and indeed a predictor of the tHcy level (Table 5) . Moreover, HGS), as compared with the patients in group I (wellthe correlations between Met and tHcy, as well as benourished group). The results of the present study show tween Met and nPNA (Table 4) , may indicate that the also that tHcy levels are consistently elevated in the HD tHcy level in HD patients was dependent on the intake patients (95%), and this change is more marked in wellof dietary protein, which is the only source of Met. Inadenourished patients, whereas malnourished patients had quate concentrations of the vitamin cofactors (folate, lower tHcy concentrations (Table 2) . Thus, one factor vitamin B 12 and vitamin B 6 ) are contributing factors for that may have directly contributed to the lower tHcy hyperhomocysteinemia. The plasma concentrations of levels in the malnourished HD patients is the lower levels folate and B 12 were within the normal range in our paof S Alb . In the general population, protein-bound Hcy tients and were similar in the well-nourished and malaccounts for more than 65% of total Hcy [23, 28, 29] nourished patients. We did not measure vitamin B 6 , but and the main Hcy carrier in plasma is S Alb [30] . In uremic our patients were routinely supplemented with pyripatients, the fraction of protein-bound Hcy is similar to doxine. that in normal subjects; however, it is higher in dialyzed Age is a determinant of both the tHcy and tCys levels, than in nondialyzed uremic patients [23] . Hence, it seems and this physiological age-related increase may be linked likely that S Alb is a strong determinant of tHcy in HD to the age-related decrease in renal function [34] . Howpatients, and this may contribute to the low tHcy levels ever, these levels were in fact lower in our older patients, in malnourished patients. possibly because they also had a lower S Alb than the Serum albumin is considered a key index of nutritional younger patients, considering that tHcy and tCys are correlated to S Alb (Table 4) . status, and it is commonly used to assess protein malnu-Homocysteine and cardiovascular disease are interrelated [5] . Hypoalbuminemia and malnutrition per se may be risk factors for cardiac disease, but cardiac In the present study, the tHcy levels in HD patients disease may also lead to malnutrition, as has been demwere three to four times higher than in the controls, onstrated in the general population [44] . Moreover, a with only 5% of the patients having normal tHcy levels, common mechanism for the development of CVD and hyperhomocysteinemia being defined as Ͼ95th percenmalnutrition might be cytokine activation associated tile of the normal range. Assuming that hyperhomocyswith reduced renal function or inflammation, since prointeinemia carries an increased risk of ICVD, this implies flammatory cytokines (interleukin-1, interleukin-6, tuthat practically all chronic HD patients are exposed to mor necrosis factor) may suppress appetite, cause muscle this risk. This is in accordance with the high prevalence of proteolysis and hypoalbuminemia, and may be involved CVD in the patients in this study and in several previous in the processes leading to atherosclerosis [5] . studies. On the other hand, our patients with ICVD had We observed that the HD patients with lower tHcy significantly lower (although still elevated) tHcy levels levels (Ͻ24 mol/L) had a significantly worse survival than those without CVD, a finding that may seem pararate than those with higher levels (Ն24 mol/L; Fig. 3 ). doxical if one assumes that hyperhomocysteinemia, in This may seem paradoxical in view of the established particular absolute tHcy levels, carry more risk for CVD.
relationship between elevated tHcy levels and increased However, these observations do not exclude a role for mortality in the general population [45] , as well as in hyperhomocysteinemia, since almost all patients would uremic patients [39] [40] [41] . However, we are aware that be exposed to this risk and since other factors might be tHcy levels are influenced by various factors such as present that confound the relationship between tHcy nutritional status, S Alb , and the presence of CVD, which levels and CVD. An interaction between hyperhomocysare interrelated in a complex manner and also may inteinemia, hyperfibrinogenemia, and lipoprotein(a) exfluence the overall mortality. Unfortunately, it is not cess has been suggested [6] . It is noteworthy that men feasible to evaluate the independent effects of tHcy and with CVD had significantly lower tHcy levels, but we these other factors on mortality because of the limited found no difference in tHcy levels between females with number of patients in the present study. Interestingly, a or without CVD. recent study by Sirrs et al also has shown that HD paConflicting findings have been reported regarding the tients with higher tHcy levels appear to have a better association between the tHcy level and the prevalence survival rate than those with lower levels [46] . of CVD in chronic renal failure patients. In the study Since both lower tHcy levels and a higher prevalence by Robinson et al in HD patients, risk factor analyses of CVD were associated with hypoalbuminemia and malshowed a significant relationship between the tHcy level nutrition, this implies that nutritional status and the S Alb and atherosclerotic CVD, even after adjustment for concentration should be taken into consideration when other risk factors [35] . Others have reported a similar evaluating tHcy as a risk factor. Currently, we do not association [36] [37] [38] . Moreover, three prospective studies know whether there is a critical plasma level at which demonstrated that a high tHcy level indeed was related Hcy becomes atherogenic in uremic patients or whether to cardiovascular events in chronic renal failure patients there is a relationship between atherogenic effects and [39] [40] [41] . In contrast, Bostom et al found no relationship absolute levels of Hcy above that critical level. Morebetween the fasting tHcy level and prevalence of CVD in over, it is not known to what extent hyperhomocysteinedialyzed uremic patients, using crude or multiple logistic mia in uremic patients acts in concert with other potential regression analyses adjusted for other risk factors [42] .
risk factors for CVD, such as hypoalbuminemia, malnuIn addition, Klusmann et al (abstract; Wien Klin Wotrition, lipid abnormalities, inflammation, hyperfibrinochenschr 110:26, 1998) reported that there was no differgenemia, and oxidative stress. Hence, the higher mortalence in tHcy levels between uremic patients with coroity in our patients with lower (although still high) tHcy nary artery disease and those without; however, they may be related to the higher prevalence of malnutrition, could not identify tHcy as an independent cardiovascular lower protein intake, and lower S Alb in the HD patients risk factor in their patients.
with CVD, considering that malnutrition is a risk factor As shown in the present study, HD patients with ICVD for mortality and that CVD is the most common cause have a higher prevalence of malnutrition and hypoalof death in ESRD patients. buminemia and a lower protein intake than those without In summary, our study indicates that tCys, nutritional ICVD. Foley et al also reported a strong relationship status, and protein intake may influence the tHcy levels between hypoalbuminemia and CVD in end-stage renal in HD patients. A higher absolute level of plasma tHcy disease (ESRD) patients, and suggested that hypoalbumin HD patients appeared to be associated with a lower inemia is an important risk factor for CVD in these prevalence of CVD and better survival, possibly related patients [43] . However, it is not clear how cardiac disease, to increased protein intake, better nutritional status, and a higher S Alb level. This apparently paradoxical relationhypoalbuminemia, and malnutrition in uremic patients
